Additional file 3 of Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease
posted on 2022-09-13, 06:57authored byEmma A. Vermeulen, Coby Eelderink, Tiny Hoekstra, Adriana J. van Ballegooijen, Pieter Raijmakers, Joline W. Beulens, Martin H. de Borst, Marc G. Vervloet
Additional file 3. Protocol changes compared the original approved protocol.